| Literature DB >> 35380250 |
Hyun-Dong Chang1,2, Andreas Radbruch3, Tilmann Kallinich3,4, Mir-Farzin Mashreghi3,5, Ahmed N Hegazy3,6, Andrey Kruglov3, Sergei Nedospasov7,8, Ria Baumgrass3.
Abstract
Helper T (Th) cells play a decisive role in triggering and maintaining chronic rheumatic inflammation. Via secretion of proinflammatory cytokines and expression of costimulatory cell surface molecules, Th lymphocytes coordinate the recruitment and activation of effector cells, which are ultimately responsible for the immunopathology and tissue destruction. However, therapeutic approaches aimed at eliminating Th cells were unsuccessful due to their lack of selectivity. At the German Rheumatism Research Center (Deutsches Rheuma-Forschungszentrum, DRFZ), we are working to improve the understanding of the Th cells involved in chronic inflammatory reactions. Based on this understanding, our aim is to develop novel treatment strategies that selectively target the pathogenic Th lymphocytes causing rheumatic inflammation. The current article summarizes the DRFZ's research activities on this subject.Entities:
Keywords: B‑lymphocytes; Chronic inflammatory disease; Inflammation mediators; Tumor necrosis factor; T‑lymphocytes, helper-inducer
Mesh:
Substances:
Year: 2022 PMID: 35380250 DOI: 10.1007/s00393-022-01186-5
Source DB: PubMed Journal: Z Rheumatol ISSN: 0340-1855 Impact factor: 1.530